These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12681236)

  • 1. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure.
    Nagaya N; Kangawa K
    Curr Opin Pharmacol; 2003 Apr; 3(2):146-51. PubMed ID: 12681236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure.
    Nagaya N; Kangawa K
    Regul Pept; 2003 Jul; 114(2-3):71-7. PubMed ID: 12832093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of ghrelin in the treatment of heart failure.
    Nagaya N; Kangawa K
    Drugs; 2006; 66(4):439-48. PubMed ID: 16597162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.
    Nagaya N; Kojima M; Kangawa K
    Intern Med; 2006; 45(3):127-34. PubMed ID: 16508225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure.
    Nagaya N; Uematsu M; Kojima M; Ikeda Y; Yoshihara F; Shimizu W; Hosoda H; Hirota Y; Ishida H; Mori H; Kangawa K
    Circulation; 2001 Sep; 104(12):1430-5. PubMed ID: 11560861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.
    Nagaya N; Moriya J; Yasumura Y; Uematsu M; Ono F; Shimizu W; Ueno K; Kitakaze M; Miyatake K; Kangawa K
    Circulation; 2004 Dec; 110(24):3674-9. PubMed ID: 15569841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches.
    Akashi YJ; Springer J; Anker SD
    Curr Heart Fail Rep; 2005 Dec; 2(4):198-203. PubMed ID: 16332313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure.
    Xu XB; Pang JJ; Cao JM; Ni C; Xu RK; Peng XZ; Yu XX; Guo S; Chen MC; Chen C
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1643-51. PubMed ID: 15951341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cachexia with ghrelin in patients with COPD.
    Nagaya N; Itoh T; Murakami S; Oya H; Uematsu M; Miyatake K; Kangawa K
    Chest; 2005 Sep; 128(3):1187-93. PubMed ID: 16162705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.
    Akamizu T; Kangawa K
    Peptides; 2011 Nov; 32(11):2295-300. PubMed ID: 21635929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function.
    Ledderose C; Kreth S; Beiras-Fernandez A
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):1-6. PubMed ID: 22074572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors.
    Nagaya N; Uematsu M; Kojima M; Date Y; Nakazato M; Okumura H; Hosoda H; Shimizu W; Yamagishi M; Oya H; Koh H; Yutani C; Kangawa K
    Circulation; 2001 Oct; 104(17):2034-8. PubMed ID: 11673342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone.
    Granata R; Isgaard J; Alloatti G; Ghigo E
    Exp Biol Med (Maywood); 2011 May; 236(5):505-14. PubMed ID: 21478211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease.
    Lainscak M; Andreas S; Scanlon PD; Somers VK; Anker SD
    Intern Med; 2006; 45(13):837. PubMed ID: 16880713
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased plasma ghrelin level in lung cancer cachexia.
    Shimizu Y; Nagaya N; Isobe T; Imazu M; Okumura H; Hosoda H; Kojima M; Kangawa K; Kohno N
    Clin Cancer Res; 2003 Feb; 9(2):774-8. PubMed ID: 12576449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and potential roles of ghrelin in clinical practice.
    Angelidis G; Valotassiou V; Georgoulias P
    J Endocrinol Invest; 2010 Dec; 33(11):823-38. PubMed ID: 21293171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ghrelin Physiology and Pathophysiology: Focus on the Cardiovascular System].
    Gruzdeva OV; Borodkina DA; Belik EV; Akbasheva OE; Palicheva EI; Barbarash OL
    Kardiologiia; 2019 Apr; 59(3):60-67. PubMed ID: 30990143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous ghrelin increases in adriamycin-induced heart failure rats.
    Xu Z; Wu W; Zhang X; Liu G
    J Endocrinol Invest; 2007 Feb; 30(2):117-25. PubMed ID: 17392601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin, growth and obesity.
    Ukkola O; Pöykkö S
    Ann Med; 2002; 34(2):102-8. PubMed ID: 12108573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin and the heart.
    Tokudome T; Otani K; Miyazato M; Kangawa K
    Peptides; 2019 Jan; 111():42-46. PubMed ID: 29791869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.